Kuzmanov A and his partners pointed out that pharmacological inhibition of PDGFBB/PDGFRβ signaling reduced vessel functionality, tumor growth and cell migration and invasion during breast carcinogenesis20. Here, PDGFRB is linked to neoplasm.